Pms19 - A Budget Impact Analysis of Introducing a Forced Treatment Pathway Using the Lowest Priced Anti-Tumor Necrosis Factor Agent for Rheumatoid Arthritis and Ankylosing Spondylitis in the Philippines

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1733
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Anti-Tumour Necrosis Factor Therapy for Ankylosing Spondylitis: International Experience

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2002English

Pms20 - Budget Impact of Introducing Secukinumab in the Treatment of Ankylosing Spondylitis From the Private Payer Perspective in Brazil

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Effectiveness and Safety of Adalimumab in Patients With Ankylosing Spondylitis or Psoriatic Arthritis and History of Anti-Tumor Necrosis Factor Therapy

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2010English

Tumor Necrosis Factor Α Antagonists in the Treatment of the Patients With Rheumatoid Arthritis

Reumatologia
RheumatologyAllergyImmunology
2012English

Cost-Minimization Analysis of Anti-TNF Biologics in the Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis Under the Brazilian Private Health Care System Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Anti-Tumor Necrosis Factor (TNF) Drugs for the Treatment of Psoriatic Arthritis: An Indirect Comparison Meta-Analysis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

De Subitaneis Mortibus. XXIII. Rheumatoid Arthritis and Ankylosing Spondylitis

Circulation
Cardiovascular MedicinePhysiologyCardiology
1977English

Raised Titres of Anti-Klebsiella IgA in Ankylosing Spondylitis, Rheumatoid Arthritis, and Inflammatory Bowel Disease

BMJ
1988English

The Status of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody Are Not Associated With the Effect of Anti-TNFα Agent Treatment in Patients With Rheumatoid Arthritis: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy